Gamgee GTM brain

Gamgee is developing personalized mRNA cancer vaccines for dogs, working with owners, veterinarians and oncology partners.

category

Personalized veterinary cancer immunotherapy

market profile

  • text: Canine cancer treatment can involve surgery, chemotherapy and immunotherapy; Gamgee is running clinical trials and registering interest globally.
  • text: Personalized veterinary oncology includes other vaccine and cell therapy approaches.

personas

  • title: Owner of a dog diagnosed with cancer
    pains:
    • Limited or unsuccessful existing treatment options
    • Needs clear eligibility, logistics and realistic expectations for an investigational treatment
  • title: Veterinary oncologist
    pains:
    • Wants additional treatment options for individual canine cancer patients
    • Needs coordinated tissue collection, vaccine delivery and response monitoring

icp

  • text: Veterinary oncology practices and specialty animal hospitals able to diagnose cancer, collect tissue and administer treatment.
  • text: Dog owners worldwide can register interest; clinical trials are based in Australia, and individual case eligibility must be confirmed.

message pillars

  • text: Treatment is tailored to a dog's cancer.
  • text: The team coordinates the process.
  • text: Veterinary specialists administer treatment and monitor response.

objections

  • objection: Is this proven to work for my dog?
    response: This is an investigational program; discuss eligibility, evidence and uncertainty with the treating oncologist.
  • objection: How complicated is access?
    response: Gamgee describes an intake process and coordination with the patient's vet, subject to case selection.

competitors

  • name: ELIAS Animal Health
    website: https://eliasanimalhealth.com/pipeline/
    why: Develops personalized vaccine-enhanced canine cancer cell therapy.
  • name: NeoCanis Therapeutics
    website: https://neocanistherapeutics.com/
    why: Developing personalized mRNA cancer vaccines for dogs.
  • name: Torigen Pharmaceuticals
    website: https://vidiumah.com/wp-content/uploads/2022/10/Vidium-and-Torigen-Partnership-Press-Release.pdf
    why: Provides personalized veterinary cancer immunotherapy.

influencers

  • name: Paul Steven Conyngham
    url: https://www.linkedin.com/posts/paustevenlconyngham_we-just-launched-gamgee-with-yc-lets-patch-activity-7493041216696221696-NO63
    why: Founder sharing launch and patient recruitment.

keywords

  • dog cancer vaccine
  • canine cancer clinical trial
  • personalized dog cancer treatment
  • veterinary oncology immunotherapy
  • dog mRNA cancer vaccine

voice

  • Empathetic
  • Hopeful
  • Patient-centered

signals

  • text: A specialty veterinary practice is recruiting canine oncology trial cases or seeking treatment alternatives.
  • text: An owner has a dog diagnosed with cancer and a treating veterinarian who can review eligibility.

pricing

model: unknown

motion

hybrid

channels

  • Founder LinkedIn
  • press
  • veterinary partnerships
  • search

confidence

medium

Founders

  • name: Paul Conyngham
    title: Founder/CEO
    role: CEO
    bio: Founder at Gamgee Technologies (YC S26), building personalised mRNA cancer vaccines for dogs. Gamgee grew out of my work using AI and genomics to help my dog Rosie fight cancer. Previously co-founded Core Intelligence, building applied AI systems across startups and enterprise, and helped grow Australia’s AI community as a founding member of the Data Science & AI association of Australia. Background in ML, data science and electrical and computer systems engineering

Back to YC companies